| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.072 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |